Cargando…

Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness

BACKGROUND: Marek's disease virus (MDV) is an economically important oncogenic herpesvirus of poultry. Since the 1960s, increasingly virulent strains have caused continued poultry industry production losses worldwide. To understand the mechanisms of this virulence evolution and to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Atkins, Katherine E, Read, Andrew F, Savill, Nicholas J, Renz, Katrin G, Walkden-Brown, Stephen W, Woolhouse, Mark EJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226581/
https://www.ncbi.nlm.nih.gov/pubmed/22078942
http://dx.doi.org/10.1186/1746-6148-7-70
_version_ 1782217645916946432
author Atkins, Katherine E
Read, Andrew F
Savill, Nicholas J
Renz, Katrin G
Walkden-Brown, Stephen W
Woolhouse, Mark EJ
author_facet Atkins, Katherine E
Read, Andrew F
Savill, Nicholas J
Renz, Katrin G
Walkden-Brown, Stephen W
Woolhouse, Mark EJ
author_sort Atkins, Katherine E
collection PubMed
description BACKGROUND: Marek's disease virus (MDV) is an economically important oncogenic herpesvirus of poultry. Since the 1960s, increasingly virulent strains have caused continued poultry industry production losses worldwide. To understand the mechanisms of this virulence evolution and to evaluate the epidemiological consequences of putative control strategies, it is imperative to understand how virulence is defined and how this correlates with host mortality and infectiousness during MDV infection. We present a mathematical approach to quantify key epidemiological parameters. Host lifespan, virus latent periods and host viral shedding rates were estimated for unvaccinated and vaccinated birds, infected with one of three MDV strains. The strains had previously been pathotyped to assign virulence scores according to pathogenicity of strains in hosts. RESULTS: Our analyses show that strains of higher virulence have a higher viral shedding rate, and more rapidly kill hosts. Vaccination enhances host life expectancy but does not significantly reduce the shedding rate of the virus. While the primary latent period of the virus does not vary with challenge strain nor vaccine treatment of host, the time until the maximum viral shedding rate is increased with vaccination. CONCLUSIONS: Our approach provides the tools necessary for a formal analysis of the evolution of virulence in MDV, and potentially simpler and cheaper approaches to comparing the virulence of MDV strains.
format Online
Article
Text
id pubmed-3226581
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32265812011-11-30 Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness Atkins, Katherine E Read, Andrew F Savill, Nicholas J Renz, Katrin G Walkden-Brown, Stephen W Woolhouse, Mark EJ BMC Vet Res Research Article BACKGROUND: Marek's disease virus (MDV) is an economically important oncogenic herpesvirus of poultry. Since the 1960s, increasingly virulent strains have caused continued poultry industry production losses worldwide. To understand the mechanisms of this virulence evolution and to evaluate the epidemiological consequences of putative control strategies, it is imperative to understand how virulence is defined and how this correlates with host mortality and infectiousness during MDV infection. We present a mathematical approach to quantify key epidemiological parameters. Host lifespan, virus latent periods and host viral shedding rates were estimated for unvaccinated and vaccinated birds, infected with one of three MDV strains. The strains had previously been pathotyped to assign virulence scores according to pathogenicity of strains in hosts. RESULTS: Our analyses show that strains of higher virulence have a higher viral shedding rate, and more rapidly kill hosts. Vaccination enhances host life expectancy but does not significantly reduce the shedding rate of the virus. While the primary latent period of the virus does not vary with challenge strain nor vaccine treatment of host, the time until the maximum viral shedding rate is increased with vaccination. CONCLUSIONS: Our approach provides the tools necessary for a formal analysis of the evolution of virulence in MDV, and potentially simpler and cheaper approaches to comparing the virulence of MDV strains. BioMed Central 2011-11-11 /pmc/articles/PMC3226581/ /pubmed/22078942 http://dx.doi.org/10.1186/1746-6148-7-70 Text en Copyright ©2011 Atkins et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Atkins, Katherine E
Read, Andrew F
Savill, Nicholas J
Renz, Katrin G
Walkden-Brown, Stephen W
Woolhouse, Mark EJ
Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness
title Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness
title_full Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness
title_fullStr Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness
title_full_unstemmed Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness
title_short Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness
title_sort modelling marek's disease virus (mdv) infection: parameter estimates for mortality rate and infectiousness
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226581/
https://www.ncbi.nlm.nih.gov/pubmed/22078942
http://dx.doi.org/10.1186/1746-6148-7-70
work_keys_str_mv AT atkinskatherinee modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness
AT readandrewf modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness
AT savillnicholasj modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness
AT renzkatring modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness
AT walkdenbrownstephenw modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness
AT woolhousemarkej modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness